Alzheimer’s prognosis models should expand data sources
By
Kristen Fischer
Aug 12, 2024
Integrating data from nursing home electronic health records (EHRs) and claims in addition to the minimum data set (MDS) — data required for nursing home residents — could be better than just relying...
Alzheimer’s care, quality of life improve with innovative immersion room
By
Jessica R. Towhey
Aug 05, 2024
A creative new room at a Long Island, NY, nursing home may serve as a model for improving the quality of Alzheimer’s care.
What happens if biomarker tests spot Alzheimer’s before people show symptoms?
By
Kristen Fischer
Aug 05, 2024
As of now, no therapy is approved by the Food and Drug Administration for people at risk of Alzheimer’s disease who don’t have symptoms. But blood tests that can spot biomarkers linked to the disease...
It’s all in the wrist: New wearable devices can provide seniors key data about Alzheimer’s, COVID
By
Aaron Dorman
Mar 13, 2024
Two research projects, on Alzheimer’s and Long COVID, highlight the unique potential for wrist wearables to monitor and detect health data.
This long-term care provider keeps the lights on without throwing sleep cycles off
By
Aaron Dorman
Nov 10, 2023
Special lighting systems can help maintain seniors’ circadian rhythms and sleep cycles, one LTC operator says.
Research focuses on diagnosing, lessening effects of Alzheimer’s disease
By
Kimberly Bonvissuto
Jun 28, 2022
More than 6 million Americans are living with Alzheimer’s disease, costing the nation $321 billion in 2022, according to the Alzheimer’s Association. A variety of studies and pilot programs are underway...
Next-gen Alzheimer’s diagnostic lets patients ‘check their brain’ from anywhere
By
Aaron Dorman
Oct 27, 2023
A new screening platform for brain disease has expanded accessibility and includes a three minute cognitive assessment.
High-tech ‘bike-helmet’ part of emerging field of light therapy for dementia, Alzheimer’s
By
Aaron Dorman
Nov 16, 2023
Light therapy is one way that seniors can both maintain and monitor their brain and cognitive function, one tech company co-founder says.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.
Visionary Alzheimer’s forecasting software gets FDA approval
By
Aaron Dorman
Jan 30, 2024
A newly regulated Alzheimer’s software tool offers clarity on whether the condition is likely to progress to dementia in someone with mild cognitive impairment.